These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2973958)

  • 1. [Mesoglycan in the treatment of chronic obstructive arteriopathies of the legs].
    Scolari EA
    Clin Ter; 1988 Jul; 126(1):43-7. PubMed ID: 2973958
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment with mesoglycan of chronic obliterative atherosclerotic arteriopathies of the legs. Hematochemical and flowmetric changes].
    di Giovanna VN
    Clin Ter; 1988 Jun; 125(6):431-4. PubMed ID: 2973949
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ozone therapy, a new method of treating chronic obliterating arteriopathies].
    Ionescu G; Pitea P; Blaj A
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1985; 34(3):207-13. PubMed ID: 2931752
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of the therapeutic efficacy and tolerability of levocarnitine propionyl in the treatment of chronic obstructive arteriopathies of the lower extremities: a multicentre controlled study vs. placebo.
    Coto V; D'Alessandro L; Grattarola G; Imparato L; Lingetti M; Mancini M; Nolfe G; Rengo F
    Drugs Exp Clin Res; 1992; 18(1):29-36. PubMed ID: 1600865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Short-term and long-term results of treatment of chronic arteriopathies of the lower limbs with nicergoline. Importance of intensive medical therapy].
    Quiroli A
    Minerva Cardioangiol; 1980 Dec; 28(12):793-804. PubMed ID: 6111767
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the therapeutic activity of hemaseril in treatment of ischemic arteriopathies and phlebopathies].
    Tattoni G; Bigazzi P; Gritta G
    Clin Ter; 1974 Mar; 69(3):225-39. PubMed ID: 4846656
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic activity of anti-platelet aggregation agents in arterial diseases].
    Delboy C; Jouve R; Escande M; Juhan I; Bouvenot G
    Sem Hop Ther; 1977 Nov; 53(9):431-40. PubMed ID: 341318
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic possibilities of lumbar sympathectomy in chronic obstructive arteriopathies of the pelvic limbs].
    Angelescu N; Cîrîc G; Popescu A; Tătaru C
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1984; 33(1):23-8. PubMed ID: 6233642
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparison between L-propionyl carnitine and physical-rehabilitative exercise in diabetics with obliterative arteriopathy of the legs (Fontaine's stage IIa)].
    Costanza G; Di Salvo A; Barone G; Verruso G; Zamueli M; Marchese G
    Minerva Cardioangiol; 1999 Dec; 47(12):649-50. PubMed ID: 10670244
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of hyperdyslipidemia in chronic atherosclerotic peripheral obliterating arteriopathies of the lower limbs].
    Bagliani A; Argenteri A; La Rosa A
    Clin Ter; 1982 Dec; 103(6):647-61. PubMed ID: 7160147
    [No Abstract]   [Full Text] [Related]  

  • 11. [Intra-arterial infusions of solcoseryl in the treatment of obliterative diseases of the peripheral arteries in the polyclinic].
    Kozlitskiĭ AP
    Vestn Khir Im I I Grek; 1982 Sep; 129(9):120-3. PubMed ID: 7147583
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of the administration of buflomedil-hydrochloride on the arterial circulation of the legs in patients with obliterative arteriopathies].
    Tallarida G; Baldoni F; Peruzzi G; Raimondi G; Grimaldi I; Visigalli G; Gristina S; Massaro M; De Martinis L; Sangiorgi M
    Cardiologia; 1983 Aug; 28(8):651-60. PubMed ID: 6687209
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experience with sulodexide (Vessel Due F) in diabetics with ischemic disease of the lower extremities].
    Utratová J; Mayer J; Elbl L; Vorlícek J; Prásek J
    Vnitr Lek; 1993 Jun; 39(6):575-80. PubMed ID: 8212613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current status of the indications for lumbar gangliectomy in chronic obstructive arteriopathies of the legs].
    Ghiringhelli C; Ghiringhelli L
    Minerva Chir; 1989 Feb; 44(3):515-7. PubMed ID: 2654722
    [No Abstract]   [Full Text] [Related]  

  • 15. [Statistical data on chronic obliterating arteriopathies of the lower extremities in the aged].
    Scotti G; Gatti A; Michetti A
    Minerva Med; 1980 Apr; 71(16):1163-8. PubMed ID: 7375032
    [No Abstract]   [Full Text] [Related]  

  • 16. [Vascular symptoms are not confined to the legs. Peripheral arterial occlusive disease especially threatens the diabetic heart].
    MMW Fortschr Med; 2004 Aug; 146(31-32):48. PubMed ID: 15529714
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical experience and instrumental evaluation of buflomedil hydrochloride in the therapy of chronic obliterative arteriopathies of the legs].
    Lucisano V; Margheriti R; Matone P; Morrieri C; Rugolo A; Corsi V
    Clin Ter; 1986 Jun; 117(6):499-509. PubMed ID: 3527536
    [No Abstract]   [Full Text] [Related]  

  • 18. [Fibrinolytic therapy in the treatment of chronic peripheral obstructive arteriopathies in the development phase].
    Spinella G; Rosato EG; Chiarenza S; Romeo S
    Angiologia; 1987; 39(2):84-8. PubMed ID: 3592294
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapeutic potential of calcium heparin in the treatment of obstructive atherosclerotic arteriopathies of the legs].
    Guagliano G; Bagliani A; Di Cello G
    Clin Ter; 1985 Dec; 115(5):341-59. PubMed ID: 3830538
    [No Abstract]   [Full Text] [Related]  

  • 20. [Digital blood flow in peripheral vascular diseases. Action of drugs: buflomedil].
    Frausini G; Rotatori P; Gaggi S; Barone A; Pupita F
    Minerva Cardioangiol; 1988 Jun; 36(6):319-22. PubMed ID: 3211330
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.